The detection of pathogenic and novel potassium channel gene variants in Kazakhstani patients highlights the clinical utility of integrating genetic testing for risk stratification and family screening in Central Asia.
: This is the first genetic study of potassium channel gene mutations in Kazakhstani patients with cardiac arrhythmias. The detection of pathogenic and novel variants highlights the clinical utility of integrating genetic testing into diagnostic and management pathways for arrhythmia syndromes. Population-specific genomic data are essential for improving risk stratification, guiding medication safety, and enabling cascade family screening in Central Asia.
Chamoieva et al. (Mon,) studied this question.